Showing 1 - 10 of 1,032
relatively low innovation score, a feature reversing the trend observed in most European Union countries. Three empirical … scenarios, one for each innovation output, are defined and analyzed following a random-effects probit panel model separately …
Persistent link: https://www.econbiz.de/10014506780
Persistent link: https://www.econbiz.de/10014293776
Persistent link: https://www.econbiz.de/10012656531
Persistent link: https://www.econbiz.de/10012818084
Persistent link: https://www.econbiz.de/10014250994
Persistent link: https://www.econbiz.de/10013190418
Persistent link: https://www.econbiz.de/10013279500
The advancement of technology in the biopharmaceutical industry has spearheaded the speed and scale of digitalization in various aspects. New drug development is becoming more complex, costly, and challenging. This paper examines how the pharmaceutical value chain model could integrate with the...
Persistent link: https://www.econbiz.de/10013171458
Persistent link: https://www.econbiz.de/10014227800
elaborating the relationship between business model, entrepreneurial orientation, innovation, and sustainable performance on the …. A business model needs to be supported by customer participation and innovation. Innovation was more influential … participation and innovation on sustainable performance through the business model was greater than the direct effect not through …
Persistent link: https://www.econbiz.de/10012221926